Philippe Busque - Mar 20, 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
SVP, GLOBAL SALES AND SERVICES
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Stock symbol
CTKB
Transactions as of
Mar 20, 2024
Transactions value $
-$14,264
Form type
4
Date filed
3/21/2024, 06:19 PM
Previous filing
Mar 8, 2024
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise +5.46K 5.46K Mar 20, 2024 Direct F1
transaction CTKB Common Stock Tax liability -$14.3K -2.13K -38.96% $6.70 3.34K Mar 20, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Options Exercise $0 -5.46K -100% $0.00* 0 Mar 20, 2024 Common Stock 5.46K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents the number of shares withheld by and surrendered to the Issuer on March 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
F3 The shares subject to the RSU Award vested on March 20, 2024.